What is the mechanism of action of Seleniso (Silvio)?

Selinexor (Selinexor) is an oral, targeted therapy that inhibits nuclear transport protein (XPO1). Its mechanism of action mainly involves the regulation of nuclear transport proteins and the influence of apoptosis pathways.

1.Inhibition of nuclear transport proteins (XPO1): The transport of nuclear transport proteins XPO1 between the nucleus and the cytoplasm is crucial for the transport of large amounts of proteins and RNA within the cell. XPO1 not only regulates protein and RNA transport in normal cells, but is also involved in the growth, proliferation and metastasis of malignant tumor cells. Seleniso (Silvio) inhibits the growth and metastasis of tumor cells by specifically binding and inhibiting XPO1 and preventing its transport of key proteins, including tumor suppressor genes and apoptosis-related proteins.

2.Regulation of the cell cycle: The inhibition of XPO1 leads to the disorder of the cell cycle and prevents the normal proliferation of tumor cells. Seleniso (Silvio) affects the cyclic process of cells by regulating the transport of cell cycle-related proteins, causing tumor cells to stall at specific stages of the cell cycle, ultimately leading to the death of tumor cells.

3.Induction of apoptosis: Seleniso (Silvio) can also inhibit the growth and survival of tumor cells by inducing apoptosis. The inhibition of XPO1 causes some tumor suppressor genes and apoptosis-related proteins to accumulate in the nucleus, thereby triggering the apoptosis pathway and promoting the self-destruction of tumor cells.

4.Regulating transcription factors: XPO1Transportation between the nucleus and the cytoplasm involves not only the transport of proteins, but also the transport of transcription factors. By inhibiting XPO1, Seleniso (Silvio) affects the nuclear transport of transcription factors, thereby changing the expression of multiple genes in cells, including tumor-related genes and apoptosis-related genes.

To sum up, Seleniso (Silvio) affects the regulation of multiple key signaling pathways in cells, including cell cycle regulation, apoptosis pathways and gene transcription regulation, by inhibiting the function of nuclear transport protein XPO1, thereby achieving the therapeutic effect of inhibiting tumor cell growth and inducing apoptosis.